{"id":2736,"date":"2018-03-06T20:54:09","date_gmt":"2018-03-06T20:54:09","guid":{"rendered":"http:\/\/www.keshop.co.ke\/ADAK\/?page_id=2736"},"modified":"2018-03-23T03:47:35","modified_gmt":"2018-03-23T03:47:35","slug":"reasoned-decisions","status":"publish","type":"page","link":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/","title":{"rendered":"Rulings"},"content":{"rendered":"<p><strong>In accordance with the Anti Doping Agency of Kenya Rules as provided under Rule 14.3 on Public Disclosure, find below a listing of athletes that have received a sanction for anti-doping violations under the ADAK Rules\u00a0and \/or the Athletes International Federation Rules . For more information about a specific rulings please click on the pdf icon<\/strong><\/p>\n\n<table id=\"tablepress-1\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Name<\/th><th class=\"column-2\">Gender<\/th><th class=\"column-3\">Sport<\/th><th class=\"column-4\">Violation<\/th><th class=\"column-5\">Ineligible From<\/th><th class=\"column-6\">Ineligible To<\/th><th class=\"column-7\">Ineligibility Period<\/th><th class=\"column-8\">Decision<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">GEOFFREY KIPYEGO<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited<br \/>\nsubstance S3. Beta-2<br \/>\nAgonists\/salbutamol<\/td><td class=\"column-5\">\t<br \/>\n19th March 2024<\/td><td class=\"column-6\">18th March, 2026<\/td><td class=\"column-7\">\t<br \/>\n\t<br \/>\n2 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Geoffrey%20Kipyego%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">BRENDA LUNYAGI MUSAMBAI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited<br \/>\nsubstances S3. Beta-2<br \/>\nAgonists\/terbutaline and S9.<br \/>\nGlucocorticoids\/prednisone<br \/>\nand its metabolite<br \/>\nprednisolone.<\/td><td class=\"column-5\">2nd April 2024<br \/>\n<\/td><td class=\"column-6\">\t<br \/>\n 2nd July, 2024<\/td><td class=\"column-7\">\t<br \/>\n3 Months<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Brenda%20Lunyagi%20Musambai%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">DAVID BETT<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited<br \/>\nsubstance 19-norandrosterone<\/td><td class=\"column-5\">\t<br \/>\n\t<br \/>\n14th May 2024<\/td><td class=\"column-6\">\t<br \/>\n13th January2026<\/td><td class=\"column-7\">20 Months<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/David%20Bett%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">PANUEL MKUNGO<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited<br \/>\nsubstances S1.1 Anabolic<br \/>\nAndrogenic Steroids<br \/>\n(AAS)\/Testosterone, 5?Adiol,<br \/>\n5?Adiol, Pregnanediol,<br \/>\nAndrosterone &amp;<br \/>\nEtiocholanolone.<\/td><td class=\"column-5\">\t<br \/>\n2nd July 2024<\/td><td class=\"column-6\">\t<br \/>\n1st July, 2025<\/td><td class=\"column-7\">1 years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Panuel%20Mkungo%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">CAROLINE JEPCHUMBA KIGEN<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading, refusing or failing to<br \/>\nsubmit to Sample Collection<\/td><td class=\"column-5\">\t<br \/>\n15th July 2024<\/td><td class=\"column-6\">14th July, 2026<\/td><td class=\"column-7\">2 years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Caroline%20Jepchumba%20Kigen%20Evading%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">ELIJAH KIBIWOTT CHERUIYOT<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Tampering or Attempted<br \/>\nTampering with any part of<br \/>\nDoping Control<\/td><td class=\"column-5\">15th July 2024<\/td><td class=\"column-6\">14th July, 2028<\/td><td class=\"column-7\">4 years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Elijah%20Kibiwott%20Cheruiyot%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">BRAVIN KIPROP<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence and Use of<br \/>\nProhibited Substance S.2<br \/>\nSalbutamol<\/td><td class=\"column-5\">22nd September 2024<\/td><td class=\"column-6\">21st September, 2026<\/td><td class=\"column-7\">2 years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Bravin%20Kiprop%20Admission.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">CAROLINE JEPTANUI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading, refusing or failing to<br \/>\nsubmit to Sample Collection. <br \/>\n <br \/>\nTampering or Attempted<br \/>\nTampering<\/td><td class=\"column-5\">6th March 2025<\/td><td class=\"column-6\">5th March, 2029<\/td><td class=\"column-7\">4 years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Caroline%20Jeptanui%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-10 even\">\n\t<td class=\"column-1\">EDWIN KIPKEMOI SEKO<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading, refusing or failing to<br \/>\nsubmit to Sample Collection. <br \/>\n <br \/>\nUse or Attempted Use by an<br \/>\nAthlete of a Prohibited<br \/>\nSubstance or a Prohibited<br \/>\nMethod <br \/>\n<\/td><td class=\"column-5\">11th August 2024<\/td><td class=\"column-6\">10th December, 2025<\/td><td class=\"column-7\">16 Months<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Edwin%20Kipkemoi%20Seko%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-11 odd\">\n\t<td class=\"column-1\">KIPCHIRCHIR SAMBU EVANS<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Whereabouts failure <br \/>\n<br \/>\n<\/td><td class=\"column-5\">11th August 2024<\/td><td class=\"column-6\">10th August, 2028<\/td><td class=\"column-7\">4 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Evans%20Sambu%20Kipchirchir%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-12 even\">\n\t<td class=\"column-1\">EDINAH JEBITOK<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Whereabouts failure <br \/>\n<br \/>\n<\/td><td class=\"column-5\"> 14th October 2024<\/td><td class=\"column-6\">13th October, 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"#\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-13 odd\">\n\t<td class=\"column-1\">TABITHA NGAO<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Whereabouts failure <br \/>\n<br \/>\n<\/td><td class=\"column-5\">5th August 2024<br \/>\n<br \/>\n<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-6\"> 4th August, 2026<br \/>\n<br \/>\n<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Tabitha%20Ngao%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-14 even\">\n\t<td class=\"column-1\">ROBERT NGETICH <br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence and Use of a<br \/>\nprohibited substance S.4<br \/>\ntrimetazidine<\/td><td class=\"column-5\">1st November 2024<br \/>\n<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-6\">31st October 2027<br \/>\n<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Robert%20Ng'etich%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-15 odd\">\n\t<td class=\"column-1\">SHARON KEMBOI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence and Use of a<br \/>\nProhibited Substance S.5<br \/>\nFurosemide<br \/>\n <br \/>\nTampering\/ Attempted<br \/>\nTampering<\/td><td class=\"column-5\">14th April 2025<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-6\">13th April 2028<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Sharon%20Kemboi%20Admission.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-16 even\">\n\t<td class=\"column-1\">DELVIN RELIN MERINGOR<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Use or Attempted Use by an<br \/>\nAthlete of a Prohibited<br \/>\nSubstance or a Prohibited<br \/>\nMethod<\/td><td class=\"column-5\">11th January 2025<br \/>\n<br \/>\n<\/td><td class=\"column-6\">10th January 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Delvine%20Relin%20Mering'or%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-17 odd\">\n\t<td class=\"column-1\">JOYLINE CHEROTICH<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance S9.<br \/>\nGlucocorticoids\/triamcinolone<br \/>\nacetonide<\/td><td class=\"column-5\">25th February 2025<br \/>\n<br \/>\n<\/td><td class=\"column-6\">24th February 2027<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Joyline%20Cherotich%20Admission.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-18 even\">\n\t<td class=\"column-1\">NATHAN KIOKO MUTUKU<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence and Use of a Prohibited Substance S9. triamcinolone acetonide<\/td><td class=\"column-5\">24th March 2025<br \/>\n<\/td><td class=\"column-6\">23rd March 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Nathan%20Kioko%20Mutuku%20Admission.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-19 odd\">\n\t<td class=\"column-1\">EDWARD ZAKAYO PINGUA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Whereabouts Failures<\/td><td class=\"column-5\">5th August 2024<\/td><td class=\"column-6\">4th August 2026<\/td><td class=\"column-7\">2 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2025\/07\/Edward%20Zakayo%20Pingua%20Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-20 even\">\n\t<td class=\"column-1\">PASKALIA CHEPKORIR KIPKOECH<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance S9. Glucocorticoids\/deflazacort metabolite desacetyldeflazacort<\/td><td class=\"column-5\">5th February 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">4th February 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Paskalia-Chepkorir-Consent-2-yrs.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-21 odd\">\n\t<td class=\"column-1\">VICTOR KIPTOO KIMUTAI<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">\t<br \/>\nPresence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/methasterone metabolite 18-Nor-17?-hydroxymethyl-17?-methyl-2?-methyl-5?-androst-13-en-3-one.<\/td><td class=\"column-5\">3rd July 2024<br \/>\n<br \/>\n<br \/>\n<\/td><td class=\"column-6\">2nd July 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Victor-Kiptoo-Kimutai-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-22 even\">\n\t<td class=\"column-1\">JOSHUA KIPLAGAT BELET<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Presence of  prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/Testosterone, 5?Adiol, 5?Adiol, Pregnanediol, Androsterone &amp; Etiocholanolone<\/td><td class=\"column-5\">13th February 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">12th February 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Joshua-Kiplangat-Belet-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-23 odd\">\n\t<td class=\"column-1\">HEZRON KARANJA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Presence of prohibited substance S9. Glucocorticoids triamcinolone acetonide<\/td><td class=\"column-5\">25th February 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">24th February 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Hezron-Karanja-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-24 even\">\n\t<td class=\"column-1\">ALFRED BIWOTT CHEMEITOI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Presence of of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone.<\/td><td class=\"column-5\">25th February 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">24th February 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><br \/>\n<a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Alfred-Biwott-Chemeitoi-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-25 odd\">\n\t<td class=\"column-1\">JOAN JERUTO<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading, Refusing or Failing to Submit to Sample Collection<\/td><td class=\"column-5\">22nd November 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">21st November 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Joan-Jeruto-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-26 even\">\n\t<td class=\"column-1\">ALLAN KIPKOECH<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/ Pregnanediol, Androsterone, Androstane, Ketoetiocholanolone, Androstanediol, Etiocholanolone, Adilos, Epitestosterone and Testosterone.<\/td><td class=\"column-5\">4th March 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">3rd March 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Allan-Kipkoech-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-27 odd\">\n\t<td class=\"column-1\">ISGAH CHERUTO<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone and its metabolite 19-noretiocholanolone<\/td><td class=\"column-5\">18th April 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">17th April 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/09\/Isgah-Cheruto-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-28 even\">\n\t<td class=\"column-1\">ALFRED OWINO OUMA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<\/td><td class=\"column-4\">Presence of prohibited substances S5. Diuretics and Masking Agents\/chlorothiazide and its metabolite 4-amino-6-chloro-1,3-benzenedisulphonamide (ACB).<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/07\/Alfred-Ouma-Owino-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-29 odd\">\n\t<td class=\"column-1\">TOBIAS ELAHETIA MAUBE<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Presence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/ oxymetholone metabolite 18-nor-17?-hydroxymethyl-2?, 17?-dimethyl-5?-androsta-13-en-3-one.<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/07\/Tobias-Elahatia-Maube-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-30 even\">\n\t<td class=\"column-1\">GIDEON KIPKOSGEI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/ Testosterone.<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/07\/Gedion-Kipkosgei-Ngetich-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-31 odd\">\n\t<td class=\"column-1\">GEORGE<br \/>\nJUMA KAJULA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<br \/>\n<\/td><td class=\"column-4\">Presence of prohibited substances S5. Diuretics and Masking Agents\/ canrenone.<\/td><td class=\"column-5\">26th December 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/07\/George-Juma-Kajula-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-32 even\">\n\t<td class=\"column-1\">WINROSE CHEPKORIR<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">\t<br \/>\nPresence of prohibited substance S9. Glucocorticoids triamcinolone acetonide.<\/td><td class=\"column-5\">22nd November 2023<\/td><td class=\"column-6\">21st November 2025<br \/>\n<br \/>\n<\/td><td class=\"column-7\">2 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/07\/Winrose-Chepkorir-Consent-X-WADA.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-33 odd\">\n\t<td class=\"column-1\">ALFRED OWINO OUMA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<\/td><td class=\"column-4\">Presence of prohibited substances S5. Diuretics and Masking Agents\/chlorothiazide and its metabolite 4-amino-6-chloro-1,3-benzenedisulphonamide (ACB).<br \/>\n<\/td><td class=\"column-5\">26th December 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Alfred-Ouma-Owino-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-34 even\">\n\t<td class=\"column-1\">TOBIAS ELAHETIA MAUBE<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<\/td><td class=\"column-4\">Presence of S1.1 Anabolic Androgenic Steroids (AAS)\/ oxymetholone metabolite 18-nor-17?-hydroxymethyl-2?, 17?-dimethyl-5?-androsta-13-en-3-one.<br \/>\n<br \/>\n<\/td><td class=\"column-5\">26th December 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">25th December 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Tobias-Elahatia-Maube-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-35 odd\">\n\t<td class=\"column-1\">CAROLINE JEPCHUMBA KIGEN<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Presence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/exogenous origin of Testosterone.<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Caroline-Jepchumba-Kigen-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-36 even\">\n\t<td class=\"column-1\">ERICK KANSHUMBA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone, Mesterolone, Boldenone, Boldione and Metenolone.<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Eric-Kanshumba-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-37 odd\">\n\t<td class=\"column-1\">OBADIA ANDABWILE MWAMPETA<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Bodybuilding<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone, Mesterolone, Boldenone, Boldione and Metenolone.<\/td><td class=\"column-5\">2nd May 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">1st May 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Obadia-Andabwile-Mwampeta-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-38 even\">\n\t<td class=\"column-1\">MATHEW KIPLAGAT SAWE<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<br \/>\n<br \/>\n<\/td><td class=\"column-4\">Tampering<\/td><td class=\"column-5\">10th July 2026<\/td><td class=\"column-6\">9th July 2030<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Mathew-Sawe-Kiplangat-Tampering-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-39 odd\">\n\t<td class=\"column-1\">ROSEMARY CHELANGAT<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances  S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics\/erythropoietin (EPO).<br \/>\n<br \/>\n<\/td><td class=\"column-5\">29th October  2023<\/td><td class=\"column-6\">28th October 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Rosemary-Chelangat-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-40 even\">\n\t<td class=\"column-1\">KEVIN NASH KIPKEMOI<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance  S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone.<br \/>\n<br \/>\n<\/td><td class=\"column-5\">5th February 2024<br \/>\n<br \/>\n<\/td><td class=\"column-6\">4th February 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Kevin-Nash-Kipkemoi-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-41 odd\">\n\t<td class=\"column-1\">VICTOR KOSKEY<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S3. Beta-2 Agonists\/salbutamol and S4. Hormone and Metabolic Modulators\/trimetazidine<br \/>\n<br \/>\n<\/td><td class=\"column-5\">13th February 2023<\/td><td class=\"column-6\">12th February 2027<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/06\/Victor-Koskey-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-42 even\">\n\t<td class=\"column-1\">ALEX KIPROP LAGAT<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence ofprohibited substance  S9. Glucocorticoids triamcinolone acetonide.<\/td><td class=\"column-5\">26th December 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">25th December 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/05\/Alex-Lagat-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-43 odd\">\n\t<td class=\"column-1\">BRENDA JEROTICH KIPRONO<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone.<\/td><td class=\"column-5\">26th December 2023<\/td><td class=\"column-6\">25th December 2027<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/05\/Brenda-Jerotich-Kiprono-Decision-1.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-44 even\">\n\t<td class=\"column-1\">AGATHA JERUTO KIMASWAI<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance hydroxy clomiphene (second\/multiple violation)<\/td><td class=\"column-5\">10th March 2022<\/td><td class=\"column-6\">9th March 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">6 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/05\/Agatha-Jeruto-Kimaswai-Appeal-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-45 odd\">\n\t<td class=\"column-1\">STEPHEN KIPCHIRCHIR KIPLAGAT<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance S1.1 Anabolic Androgenic Steroids (AAS) Pregnanediol, Androsterone and Etiocholanolone<\/td><td class=\"column-5\">18th April 2024<\/td><td class=\"column-6\">17th April 2028<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/05\/Stephen-Kipchirchir-Kiplagat-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-46 even\">\n\t<td class=\"column-1\">JOHN KARIUKI GIKONYO<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of Prohibited substances S4. Hormone and Metabolic Modulators\/trimetazidine.<\/td><td class=\"column-5\">8th May 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">7th May 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/01\/John-Kariuki-Gikonyo-Consent.pdf \"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-47 odd\">\n\t<td class=\"column-1\">MICHEAL SARUNI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading, Refusing or Failing to Submit to Sample Collection<\/td><td class=\"column-5\">31st August 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">30th August 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/01\/Michael-Saruni-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-48 even\">\n\t<td class=\"column-1\">BETTY CHELANGAT<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/Methasterone and its metabolites 2?,17?-dimethyl-5?-androstane-3?,17?-diol, 18-nor-17?-hydroxymethyl-17?-methyl-2?-methyl-5?-androst-13-en-3-one (LTM)<\/td><td class=\"column-5\">12th September 2023<\/td><td class=\"column-6\">11th September 2026<\/td><td class=\"column-7\">3 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/01\/Betty-Chelangat-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-49 odd\">\n\t<td class=\"column-1\">SAMUEL LOMOI<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance Triamcinolone acetonide<\/td><td class=\"column-5\">12th September 2023<\/td><td class=\"column-6\">11th September 2027<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2024\/01\/Samuel-Lomoi-Ruling.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-50 even\">\n\t<td class=\"column-1\">AGNES MUMBUA<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/Methasterone and its metabolite 2?,17?-dimethyl-5?-androstane 3?,17?-diol<\/td><td class=\"column-5\">27th February 2023<\/td><td class=\"column-6\">26th February 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/10\/Agnes-Mumbua-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-51 odd\">\n\t<td class=\"column-1\">BRENDA CHEBET<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances for S1.1 Anabolic Androgenic Steroids (AAS)\/Methasterone and its metabolites 2?,17?-dimethyl-5? androstane-3?,17?-diol, 18-nor-17?-hydroxymethyl-17?-methyl-2?-methyl-5?-androst-13-en-3-one (LTM).<\/td><td class=\"column-5\">3rd September 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">2nd September 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/10\/Brenda-Chebet-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-52 even\">\n\t<td class=\"column-1\">HANNAH WAIRIMU MWANGI<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone and its metabolite 19-noretiocholanolone.<br \/>\n<br \/>\n<\/td><td class=\"column-5\">21st June 2023<\/td><td class=\"column-6\">20th June 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/10\/Hannah-Wairimu-Mwangi-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-53 odd\">\n\t<td class=\"column-1\">CYNTHIA KENDI<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone and its metabolite 19-noretiocholanolone.<br \/>\n<br \/>\n<\/td><td class=\"column-5\">21st June 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">20th June 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">3 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/10\/Cynthia-Kendi-Consent.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-54 even\">\n\t<td class=\"column-1\">ELIUD KIBET TOO<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosterone and 19-noretiocholanolone<\/td><td class=\"column-5\">14th September 2023<\/td><td class=\"column-6\">13th September 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/10\/Eliud-Kibet-Too-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-55 odd\">\n\t<td class=\"column-1\">JARINTER MAWIA MWASYA<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics\/erythropoietin (EPO) and Pregnanediol, Androsterone, Androstane, Ketoetiocholanolone, Androstanediol, Etiocholanolone, Adilos, Epitestosterone and Testosterone.<\/td><td class=\"column-5\">31st August 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">30th August 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/09\/Jarinter-Mawia-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-56 even\">\n\t<td class=\"column-1\">MICHAEL KIBET<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances  S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics\/erythropoietin (EPO).<\/td><td class=\"column-5\">29th June 2023<br \/>\n<br \/>\n<\/td><td class=\"column-6\">28th June 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/09\/Michael-Kibet-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-57 odd\">\n\t<td class=\"column-1\">OLUOCH BRANDON ABEDNEGO<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Body Building<\/td><td class=\"column-4\">Presence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/metandienone metabolites 6?-hydroxy-metandienone, 17?- methyl-5?-androstane-3?,17?-diol, 17?-methyl-5?-androst-1-ene-3?,17?-diol (Epimetendiol), 17?-hydroxymethyl,17?-methyl-18-nor-androst-1,4,13-trien-3-one (LTM), 17,17-dimethyl-18-nor-5b-androsta-1,13-dien-3?-ol.<\/td><td class=\"column-5\">20th July 2023<\/td><td class=\"column-6\">19th July 2027<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/07\/Brandon-Oluoch-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-58 even\">\n\t<td class=\"column-1\">WESONGA JOSEPH WASIKE<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Body Building<\/td><td class=\"column-4\">Presence of prohibited substances  2.3 S1.1 Anabolic Androgenic Steroids (AAS)\/trenbolone and its metabolite 17?-hydroxyestr-4,9,11-trien-3-one (Epitrenbolone) and S4. Hormone and Metabolic Modulators\/letrozole metabolite Bis-(4-cyanophenyl)methanol.<\/td><td class=\"column-5\">29th June 2023<\/td><td class=\"column-6\">28th June 2027<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/07\/Joseph-Wesonga-Decison.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-59 odd\">\n\t<td class=\"column-1\">KELI EVERLYNE SYOMBUA<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">\t<br \/>\nPresence of prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/19-norandrosteronc and 19-noretiocholanelone<\/td><td class=\"column-5\">12th June 2022<br \/>\n<br \/>\n<\/td><td class=\"column-6\">11th June 2026<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/06\/Keli-Everlyne-Syombua-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-60 even\">\n\t<td class=\"column-1\">PERISTER BOSIRE MORANGI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of  prohibited substances S1.1 Anabolic Androgenic Steroids (AAS)\/ Methasterone and its metabolites, dymethyl-5, androstrane-3, 17B-diol, 18-nor-17, hydroxymethyl-17, methyl-2, methyl-5 and androst-13-en-3-one.<\/td><td class=\"column-5\">28th July 2022<br \/>\n<br \/>\n<\/td><td class=\"column-6\">27th June 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/06\/Perister-Morangi-Bosire-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-61 odd\">\n\t<td class=\"column-1\">TEDDY OTIEGO OSOK<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Football<\/td><td class=\"column-4\">Presence of  prohibited substance Boldenone and its metabolites 5p-androst-1-17{3-ol-3-one (boldenone M1), epi-boldenone (17a-boldenone).<\/td><td class=\"column-5\">21st March 2022<br \/>\n<br \/>\n<\/td><td class=\"column-6\">20th March 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/06\/Teddy-Osok-Consolidated-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-62 even\">\n\t<td class=\"column-1\">ESTHER CHESANG KAKURI<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance triamcinolone acetonide<\/td><td class=\"column-5\">11th May 2022<\/td><td class=\"column-6\">11th May 2026<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><br \/>\n<a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/04\/Kakuri-Esther-Chesang-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-63 odd\">\n\t<td class=\"column-1\">VINCENT KIPLANGAT KOSKEI<br \/>\n<br \/>\n<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substances Pregnanediol, Androsterone, Androstane, Ketoetiocholanolone, Androstanediol, Etiocholanolone, Adilos, Epitestosterone and Testosterone<\/td><td class=\"column-5\">15th November 2021<\/td><td class=\"column-6\">15th November 2024<\/td><td class=\"column-7\">3 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/04\/VINCENT-KIPLANGAT-KOSKEI-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-64 even\">\n\t<td class=\"column-1\">SAMUEL LOMOI<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance Triamcinolone acetonide<\/td><td class=\"column-5\">12th September 2021<\/td><td class=\"column-6\">12th September 2025<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/04\/Samuel-Lomoi-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-65 odd\">\n\t<td class=\"column-1\">ALICE APROT NAWOWUMA<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance Letrozole Metabolite Bis-(4-Cyanophenyl) Methanol<\/td><td class=\"column-5\">14th July 2022<\/td><td class=\"column-6\">13th July 2028<\/td><td class=\"column-7\">4 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/03\/Alice-Aprot-Nawowuma-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-66 even\">\n\t<td class=\"column-1\">GEORGINA JEPKIRUI RONO<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Evading sample collection<\/td><td class=\"column-5\">26th January 2023<\/td><td class=\"column-6\">25th January 2027<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/01\/Georgina-Jepkirui-Rono-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-67 odd\">\n\t<td class=\"column-1\">WHYVONE ISUZA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Football<\/td><td class=\"column-4\">Refusing to submit to sample collection<\/td><td class=\"column-5\">15th September 2021<\/td><td class=\"column-6\">15th September 2025<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/01\/WYVONNE-ISUZA-DECISION.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-68 even\">\n\t<td class=\"column-1\">HENRY KOSGEY CHERUIYOT<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance Methylprednisolone<\/td><td class=\"column-5\">6th February 2019<\/td><td class=\"column-6\">Lifetime<\/td><td class=\"column-7\">Lifetime<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2023\/01\/HENRY-KOSGEI-DECISION.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-69 odd\">\n\t<td class=\"column-1\">SOLOMON LEKUTA<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of prohibited substance 19-Norandrosterone<\/td><td class=\"column-5\">30th November 2021<\/td><td class=\"column-6\">30th November 2025<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2022\/12\/Solomon-Lekuta-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-70 even\">\n\t<td class=\"column-1\">JUDITH JEPNGETICH<br \/>\n<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">presence of 19-Norandrosterone, 19- Nor etiocholanolone and Nandrolone(19-norandrosterone).<br \/>\n<br \/>\n<\/td><td class=\"column-5\">24th August 2021<br \/>\n<br \/>\n<\/td><td class=\"column-6\">24th August 2025<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2022\/05\/Judith-Jepngetich-Decision-1.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-71 odd\">\n\t<td class=\"column-1\">JOAN NANCY ROTICH<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Violation of the Prohibition of Participation During Ineligibility<\/td><td class=\"column-5\">28th February 2023<\/td><td class=\"column-6\">28th February 2027<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2022\/05\/Joan-Nancy-Rotich-Decision.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-72 even\">\n\t<td class=\"column-1\">PURITY JERONO TALAM<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Violation of the Prohibition of Participation During Ineligibility<br \/>\n<br \/>\n<\/td><td class=\"column-5\">12th February 2022<br \/>\n<br \/>\n<\/td><td class=\"column-6\">12th February 2026<br \/>\n<br \/>\n<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2021\/08\/DECISION-PURITY-JERONO.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-73 odd\">\n\t<td class=\"column-1\">MICHEAL OGUNDA ODHIAMBO<\/td><td class=\"column-2\">M<\/td><td class=\"column-3\">Boxing<\/td><td class=\"column-4\">Violation of the Prohibition of Participation During Ineligibility<br \/>\n<br \/>\n<\/td><td class=\"column-5\">5th February 2022<\/td><td class=\"column-6\">5th February 2026<\/td><td class=\"column-7\">4 Years<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2021\/01\/DECISION-MICHAEL-OGUDA.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<tr class=\"row-74 even\">\n\t<td class=\"column-1\">BEATRICE JEPKORIR RUTTO<\/td><td class=\"column-2\">F<\/td><td class=\"column-3\">Athletics<\/td><td class=\"column-4\">Presence of  prohibited substances Heptaminol and Enobosarm<\/td><td class=\"column-5\">4th June 2019<br \/>\n<br \/>\n<\/td><td class=\"column-6\">4th June 2025<br \/>\n<br \/>\n<\/td><td class=\"column-7\">6 Years<br \/>\n<br \/>\n<\/td><td class=\"column-8\"><a href=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2021\/01\/REASONED-DECISION-BEATRICE-JEPKORIR-RUTTO.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/adak.or.ke\/dev1.0\/wp-content\/uploads\/2018\/03\/pdf-flat-3.png\" alt=\"\" width=\"25\" height=\"25\" class=\"aligncenter size-full wp-image-3002\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1 from cache -->\n","protected":false},"excerpt":{"rendered":"<p>In accordance with the Anti Doping Agency of Kenya Rules as provided under Rule 14.3 on Public Disclosure, find below a listing of athletes that have received a sanction for anti-doping violations under the ADAK Rules\u00a0and \/or the Athletes International Federation Rules . For more information about a specific rulings please click on the pdf &hellip; <a href=\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rulings&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2736","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rulings - Anti-Doping Agency of Kenya<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rulings - Anti-Doping Agency of Kenya\" \/>\n<meta property=\"og:description\" content=\"In accordance with the Anti Doping Agency of Kenya Rules as provided under Rule 14.3 on Public Disclosure, find below a listing of athletes that have received a sanction for anti-doping violations under the ADAK Rules\u00a0and \/or the Athletes International Federation Rules . For more information about a specific rulings please click on the pdf &hellip; Continue reading &quot;Rulings&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\" \/>\n<meta property=\"og:site_name\" content=\"Anti-Doping Agency of Kenya\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-23T03:47:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\",\"url\":\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\",\"name\":\"Rulings - Anti-Doping Agency of Kenya\",\"isPartOf\":{\"@id\":\"https:\/\/adak.or.ke\/dev1.0\/#website\"},\"datePublished\":\"2018-03-06T20:54:09+00:00\",\"dateModified\":\"2018-03-23T03:47:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/adak.or.ke\/dev1.0\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rulings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/adak.or.ke\/dev1.0\/#website\",\"url\":\"https:\/\/adak.or.ke\/dev1.0\/\",\"name\":\"Anti-Doping Agency of Kenya\",\"description\":\"To advise the Government on all relevant matters relating to anti-doping\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/adak.or.ke\/dev1.0\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rulings - Anti-Doping Agency of Kenya","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/","og_locale":"en_US","og_type":"article","og_title":"Rulings - Anti-Doping Agency of Kenya","og_description":"In accordance with the Anti Doping Agency of Kenya Rules as provided under Rule 14.3 on Public Disclosure, find below a listing of athletes that have received a sanction for anti-doping violations under the ADAK Rules\u00a0and \/or the Athletes International Federation Rules . For more information about a specific rulings please click on the pdf &hellip; Continue reading \"Rulings\"","og_url":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/","og_site_name":"Anti-Doping Agency of Kenya","article_modified_time":"2018-03-23T03:47:35+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/","url":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/","name":"Rulings - Anti-Doping Agency of Kenya","isPartOf":{"@id":"https:\/\/adak.or.ke\/dev1.0\/#website"},"datePublished":"2018-03-06T20:54:09+00:00","dateModified":"2018-03-23T03:47:35+00:00","breadcrumb":{"@id":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/adak.or.ke\/dev1.0\/reasoned-decisions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/adak.or.ke\/dev1.0\/"},{"@type":"ListItem","position":2,"name":"Rulings"}]},{"@type":"WebSite","@id":"https:\/\/adak.or.ke\/dev1.0\/#website","url":"https:\/\/adak.or.ke\/dev1.0\/","name":"Anti-Doping Agency of Kenya","description":"To advise the Government on all relevant matters relating to anti-doping","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adak.or.ke\/dev1.0\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/pages\/2736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/comments?post=2736"}],"version-history":[{"count":0,"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/pages\/2736\/revisions"}],"wp:attachment":[{"href":"https:\/\/adak.or.ke\/dev1.0\/wp-json\/wp\/v2\/media?parent=2736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}